VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EXPO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EXPOExponent, Inc.
$61.18$3.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEXPOBalance Sheet

Exponent, Inc. (EXPO) Balance Sheet

30Y historyFree accessUpdated daily

The firm maintains a disciplined capital structure with a debt-to-equity ratio of 0.24 and a current ratio of 2.40, providing a stable buffer against project-based revenue cyclicality.

EXPO Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Jan'25Dec'23Dec'22Dec'21Jan'21Jan'20Dec'18Dec'17Dec'16Jan'16Jan'15Jan'14Dec'12Dec'11Dec'10Jan'10Jan'09Dec'07Dec'06Dec'05Dec'04Jan'04Jan'03Dec'01Dec'00Dec'99Jan'99Jan'98Jan'97
Total Current Assets340.89M427.58M446.88M379.53M349.16M452.76M366.83M364.04M326.61M315.51M274.04M273.81M266.5M249.38M235.44M198.58M194.59M148.33M130.31M132.76M112.01M120.17M103.46M81.75M66.26M51.06M43.44M42.23M45.1M47.2M49.4M
Cash & Short-Term Investments118.55M221.93M258.9M187.15M161.46M297.69M242.53M231.6M208.55M196.4M173.72M171.59M154.4M156.12M134.15M109.7M106.55M75.39M57.37M63.73M58.08M68.9M60.05M41.76M22.48M7.82M6.38M06.1M8.4M4.5M
Cash Only118.55M221.93M258.9M187.15M161.46M297.69M197.53M176.44M127.06M124.79M114.97M125.75M129.49M122.95M113.27M84.44M106.55M67.89M32.6M10.7M5.24M13.22M6.98M19.49M22.48M7.82M6.38M06.1M8.4M4.5M
Short-Term Investments00000045M55.16M81.5M71.6M58.76M45.84M24.91M33.17M20.88M25.26M07.49M24.77M53.03M52.84M55.68M53.07M22.27M0000000
Accounts Receivable197.34M181.51M161.41M167.36M170.11M139.86M111.56M120.14M105.81M110.1M87.41M88.58M86.37M76.98M85.36M73.06M72.03M62.66M62.21M59.82M48.21M46.21M38.59M35.84M38.4M38.61M32.26M38.49M33.9M27.3M19.7M
Days Sales Outstanding110.78113.83105.48113.8120.97109.48101.83105.11101.76115.55101.26103.35103.4694.87106.4697.89105.7100.3799.22106.43104.43108.6892.9693.67111.2134.85115.89150.64144.72135.57122.5
Inventory00000000000011M8.13M400K1.6M0100K0000000000000
Days Inventory Outstanding------------259.16184.145.63.2-0.22-------------
Other Current Assets25M24.14M26.57M25.02M17.59M012.74M7.53M12.24M9.01M12.91M014.73M8.13M7.66M7.29M5.43M10.28M4.46M3.45M2.23M5.06M2.21M2.05M1.93M2.17M4.8M3.73M5.1M11.5M25.2M
Total Non-Current Assets346.49M381.04M330.39M267.25M237.5M230.98M226.94M199.37M142.32M124.08M129.7M113.7M98.8M92.48M79.97M70.21M64.3M58.15M52.78M49.63M49.21M44.08M40.62M40.09M40.95M39.98M42.19M38.22M41.9M41.1M31.2M
Property, Plant & Equipment142.33M145.36M148.25M99.92M83.55M74.34M79.14M84.59M46.1M35.01M36.71M28.48M28.26M28.72M27.45M27.21M27.27M29.11M31.37M29.41M29.58M29.84M30.21M30.79M31.71M32.64M34.01M29.47M32.1M30.3M28.8M
Fixed Asset Turnover4.18x4.00x3.77x5.37x6.14x6.27x5.05x4.93x8.23x9.93x8.58x10.98x10.78x10.31x10.66x10.01x9.12x7.83x7.29x6.98x5.70x5.20x5.02x4.54x3.97x3.20x2.99x3.17x2.66x2.43x2.04x
Goodwill8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M08.61M00000001.9M
Intangible Assets0000000000000000000008.61M08.61M8.57M6.58M7.25M7.85M8.6M9M0
Long-Term Investments0000000-36.82M-34.09M-30.44M-42.17M-39.46M-13K29K19K40K-12.94M10K28K-34K-44K18K032K-900K-400K-100K00-1.1M-2.9M
Other Non-Current Assets131.65M128.9M116.4M104.9M91.44M101.48M84.97M106.17M87.61M80.46M84.38M76.61M37.33M34.02M25.54M19.66M28.42M9.94M5.88M5.68M6.47M3.46M1.67M-539K675K760K933K905K1.2M1.8M2.4M
Total Assets687.38M808.62M777.27M646.78M586.66M683.74M593.77M563.41M468.94M439.59M403.74M387.51M365.3M341.86M315.42M268.79M258.89M206.48M183.09M182.39M161.22M164.24M144.08M121.84M107.22M91.03M85.63M80.45M87M88.3M80.6M
Asset Turnover0.80x0.72x0.72x0.83x0.87x0.68x0.67x0.74x0.81x0.79x0.78x0.81x0.83x0.87x0.93x1.01x0.96x1.10x1.25x1.12x1.05x0.94x1.05x1.15x1.18x1.15x1.19x1.16x0.98x0.83x0.73x
Asset Growth %3.52%4.03%20.18%10.25%-14.2%15.15%5.39%20.15%6.68%8.88%4.19%6.08%6.86%8.38%17.35%3.82%25.38%12.78%0.38%13.13%-1.84%13.99%18.25%13.64%17.78%6.32%6.43%-7.53%-1.47%9.55%3.73%
Total Current Liabilities142.2M178M163.18M161.91M159.03M152.98M117.31M123.96M98.3M93.11M80.24M80.47M79.34M69.84M71.77M60.77M57.73M45.08M48.23M43.96M30.73M26.41M24.54M24.23M21.57M19.31M19.4M15.56M12.5M13.8M11.8M
Accounts Payable37.35M6.87M5.27M4.49M8.64M3.19M3.28M4.64M2.55M2.78M3.19M3.62M2.23M2.8M7.01M4.21M02.16M3.75M4.12M2.85M4.14M4.33M4.84M5.18M4.65M4.23M4.04M2.2M2M4M
Days Payables Outstanding19.065.754.624.099.043.413.9465.6837.4256.0373.477.1952.5363.3398.078.42-4.868.7634.4132.9448.7750.0355.83107.3897.67123.85124.311.8312.9433.26
Short-Term Debt6.71M6.89M00005.99M5.94M00000000000000055K205K359K839K415K1.7M1.2M1.3M
Deferred Revenue (Current)58.99M18.87M16.37M21.71M18.83M19.76M11.8M12.71M9.17M8.3M7.62M7.8M8.23M6.77M6.67M5.95M6.13M4.76M6.17M6.46M4.07M2.36M1.68M2.86M1.51M1.41M00000
Other Current Liabilities024.07M14.98M13.17M10.17M9.38M13.05M0000000002.75M2.34M00000-55K0014.33M11.1M8.6M10.6M6.5M
Current Ratio2.40x2.40x2.74x2.34x2.20x2.96x3.13x2.94x3.32x3.39x3.42x3.40x3.36x3.57x3.28x3.27x3.37x3.29x2.70x3.02x3.65x4.55x4.22x3.37x3.07x2.64x2.24x2.71x3.61x3.42x4.19x
Quick Ratio2.40x2.40x2.74x2.34x2.20x2.96x3.13x2.94x3.32x3.39x3.42x3.40x3.22x3.45x3.27x3.24x3.37x3.29x2.70x3.02x3.65x4.55x4.22x3.37x3.07x2.64x2.24x2.71x3.61x3.42x4.19x
Cash Conversion Cycle91.72-----------310.09215.6813.9992.66-95.73-------------
Total Non-Current Liabilities206.85M240.27M193.02M128.78M106.88M113.69M114.97M89.2M56.72M57.39M50.16M44.23M41.67M36.96M27.22M21.3M17.36M11.33M6.76M6.51M6.18M4.63M2.56M2.41M1.86M1.19M886K4.75M16.2M17.8M19.5M
Long-Term Debt00000000000000000000000169K167K81K227K4.14M16.1M16.7M18.5M
Capital Lease Obligations300.85M75.94M76.08M21.96M13.34M9.81M14.34M18.16M00000000000000000000000
Deferred Tax Liabilities31.1M31.1M000013.68M14.17M3.36M5.51M6.87M5.79M11M8.13M7.66M7.29M00000001.21M860K414K0001.1M1M
Other Non-Current Liabilities132.52M133.23M116.94M106.82M93.54M103.89M86.95M71.04M56.72M57.39M50.16M42.23M41.67M36.96M27.22M19.46M17.36M11.33M4.97M6.51M6.18M4.63M2.56M1.03M837K697K659K609K100K00
Total Liabilities349.04M418.27M356.2M290.69M265.91M266.67M232.28M213.16M155.03M150.5M130.4M124.7M121.01M106.8M98.99M82.07M75.09M56.41M55M50.47M36.91M31.04M27.1M26.64M23.43M20.5M20.29M20.3M28.7M31.6M31.3M
Total Debt81.04M82.83M81.48M28.26M18.6M14.97M20.33M24.1M000000000000000224K372K440K1.07M4.55M17.8M17.9M19.8M
Net Debt-37.52M-139.1M-177.42M-158.89M-142.86M-282.72M-177.19M-152.33M-127.06M-124.79M-114.97M-125.75M-129.49M-122.95M-113.27M-84.44M-106.55M-67.89M-32.6M-10.7M-5.24M-13.22M-6.98M-19.27M-22.11M-7.38M-5.31M4.55M11.7M9.5M15.3M
Debt / Equity0.24x0.21x0.19x0.08x0.06x0.04x0.06x0.07x---------------0.00x0.00x0.01x0.02x0.08x0.31x0.32x0.40x
Debt / EBITDA0.64x0.64x0.63x0.24x0.13x0.13x0.23x0.26x---------------0.01x0.02x0.03x0.07x0.37x2.02x1.77x3.88x
Net Debt / EBITDA-0.30x-1.07x-1.37x-1.32x-0.97x-2.45x-1.97x-1.66x-1.30x-1.59x-1.69x-1.69x-1.88x-2.02x-1.82x-1.46x-2.24x-1.81x-0.80x-0.32x-0.22x-0.56x-0.31x-0.95x-1.27x-0.52x-0.35x0.37x1.33x0.94x3.00x
Interest Coverage------------------3338.36x2402.79x----------1.13x
Total Equity338.34M390.34M421.07M356.08M320.75M417.06M361.5M350.25M313.91M289.09M273.35M262.8M244.29M235.06M216.43M186.72M183.8M150.07M128.09M131.92M124.31M133.2M116.98M95.2M83.79M70.53M65.34M60.15M58.3M56.7M49.3M
Equity Growth %-23.66%-7.3%18.25%11.02%-23.09%15.37%3.21%11.58%8.59%5.76%4.01%7.58%3.93%8.61%15.91%1.59%22.48%17.16%-2.9%6.13%-6.68%13.86%22.88%13.62%18.79%7.95%8.63%3.17%2.82%15.01%1.86%
Book Value per Share6.757.628.176.906.147.826.786.505.805.365.034.814.414.193.793.163.052.502.042.021.811.901.711.491.391.231.151.090.950.960.92
Total Shareholders' Equity338.34M390.34M421.07M356.08M320.75M417.06M361.5M350.25M313.91M289.09M273.35M262.8M244.29M235.06M216.43M186.72M183.8M150.07M128.09M131.92M124.31M133.2M116.98M95.2M83.79M70.53M65.34M60.15M58.3M56.7M49.3M
Common Stock66K66K66K66K66K66K66K66K66K33K33K33K16K16K16K16K16K16K16K16K16K8K8K8K8K8K8K8K000
Retained Earnings682.01M668.42M624.15M574.08M528.81M478.37M421.81M384.67M342.02M303.99M291.24M269.26M246.96M226.04M206.06M179.43M156.09M139.61M127.13M113.02M101.23M88.32M75.53M66.46M56.3M48.37M42.25M34.47M29.6M25.8M21.6M
Treasury Stock-645.61M-645.61M-545.05M-536.53M-505.54M-340.81M-323.77M-277.66M-252.61M-223.17M-209.44M-184.5M-162.01M-132.36M-113.09M-100.33M-67.94M-72.99M-71.44M-41.23M-27.83M00-5.45M-6.38M-10.24M-9.84M-7.67M000
Accumulated OCI-2.57M-2.29M-3.79M-2.98M-3.59M-1.98M-1.93M-1.76M-2.85M-2.03M-3.13M-1.8M-904K109K-250K-471K-451K-367K-345K347K93K-2.01M-844K94K-39K-116K-97K-66K-32.1M-33M100K
Minority Interest0000000000000000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityStrong
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Working Capital Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Capital Base Reflects Operational Shifts

According to recent balance sheet filings, Exponent's total assets grew from $662.3 million in 2023Q4 to $687.4 million in 2026Q1, reflecting a measured expansion of the firm's resource base despite the inherent volatility associated with its project-based forensic consulting model and periodic capital return initiatives.

The expansion in total assets appears driven by a strategic increase in property and equipment, suggesting the firm is investing in the laboratory infrastructure necessary to maintain its competitive moat. Investors should monitor whether this asset growth translates into sustained revenue productivity or if it merely reflects the rising cost of maintaining specialized technical facilities.

Conservative Leverage Supports Financial Flexibility

As reported in financial statements, Exponent maintains a conservative debt-to-equity ratio of 0.24 as of 2026Q1, demonstrating a disciplined approach to capital structure that provides the firm with significant insulation against the cyclicality of its high-stakes litigation and forensic consulting revenue streams.

The modest increase in debt levels over the last ten quarters appears strategic rather than necessity-driven, likely utilized to optimize the balance sheet while maintaining liquidity. This low leverage profile suggests the firm retains substantial capacity to fund operations or pursue opportunistic growth without relying on external financing.

Liquidity Buffer Remains Structurally Sound

Based on the provided figures, Exponent's current ratio stood at 2.40 in 2026Q1, indicating a robust liquidity position that provides a sufficient buffer against the lumpy cash flow cycles and working capital outflows inherent in the firm's specialized, project-based consulting business model.

While the current ratio has fluctuated from a high of 3.32 in 2025Q1, the firm consistently maintains a strong ability to cover short-term obligations. This liquidity strength is essential for managing the timing mismatches between project execution and client payments, which often create temporary pressure on operating cash flow.

Shareholder Returns Impact Equity Quality

Analysis of recent filings reveals that Exponent's equity base has remained relatively stable at $338.3 million in 2026Q1, despite aggressive capital deployment strategies, including significant share repurchases that have effectively offset the growth in retained earnings over the observed ten-quarter period.

The firm's commitment to returning capital to shareholders appears to be a core component of its financial strategy, though it necessitates careful monitoring of the impact on long-term book value. Investors should consider whether this focus on buybacks limits the firm's ability to reinvest in the specialized talent and infrastructure required for future growth.

EXPO — Frequently Asked Questions

Quick answers to the most common questions about buying EXPO stock.

What are the total assets of Exponent, Inc. (EXPO)?

As of 2025, Exponent, Inc. (EXPO) had total assets of $808.6M including $427.6M in current assets.

How much debt does Exponent, Inc. (EXPO) have?

Exponent, Inc. (EXPO) carries total debt of $82.8M, offset by $221.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Exponent, Inc.?

Exponent, Inc. (EXPO) has total shareholders' equity (book value) of $390.3M ($7.62 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Exponent, Inc.'s current ratio and liquidity?

Exponent, Inc. (EXPO) reported a current ratio of 2.40x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.